Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06960291 | Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada(EXCEL) | recruiting | N/A | 740 | University of CalgaryOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT07141121 | Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen(IMARHGIN) | recruiting | N/A | 78 | Icahn School of Medicine at Mount SinaiOTHER | 1 |
| Oct 7, 2025 |
| clinicaltrials |
| NCT07209878 | 68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI | recruiting | Phase 2 / Phase 3 | 100 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT07210502 | Side Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate Cancer(LDR BURST) | not yet recruiting | N/A | 220 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Oct 7, 2025 | clinicaltrials |
| NCT05869682 | Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy | recruiting | Phase 2 | 210 | City of Hope Medical CenterOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT06433349 | A Multi-center Investigation of Family Health. | recruiting | — | 240 | Odense University HospitalOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT07207902 | Surveillance or Focal Therapy(SOFT) | active not recruiting | N/A | 400 | Kaiser PermanenteOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT05603559 | 177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer | recruiting | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT06517901 | Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer(FOCUS-PC) | recruiting | N/A | 1,306 | Albany Medical CollegeOTHER | 2 | Oct 3, 2025 | clinicaltrials |
| NCT05346848 | Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer(DARIUS) | recruiting | Phase 2 | 62 | Institut BergoniéOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT06824818 | Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients | recruiting | N/A | 155 | University of ChicagoOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT00261456 | The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer | active not recruiting | — | 3,500 | Institute of Cancer Research, United KingdomOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT02705846 | Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations(GENPROS) | recruiting | — | 4,260 | Institute of Cancer Research, United KingdomOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT03158922 | The BARCODE 1 Pilot Study(BARCODE1Pilot) | active not recruiting | — | 329 | Institute of Cancer Research, United KingdomOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT04993508 | Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance Imaging(PRIMA) | not yet recruiting | N/A | 1,908 | Heinrich-Heine University, DuesseldorfOTHER | 0 | Sep 26, 2025 | clinicaltrials |
| NCT06817668 | Evaluating Tolerability of ePUHRT With Brachytherapy Boost | recruiting | N/A | 31 | Indiana UniversityOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT07055165 | Connect2Care: Prostate Cancer Education and Screenings for African American Men | recruiting | N/A | 466 | University of OklahomaOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT03814252 | Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate Cancer(PRO-TULSA-PC) | active not recruiting | N/A | 62 | Turku University HospitalOTHER_GOV | 1 | Sep 22, 2025 | clinicaltrials |
| NCT05324332 | 68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients | recruiting | N/A | 50 | Peking Union Medical College HospitalOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT02194842 | Phase III Radium 223 mCRPC-PEACE III(PEACE III) | active not recruiting | Phase 3 | 446 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Sep 19, 2025 | clinicaltrials |
| NCT02972060 | ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer | active not recruiting | Phase 2 | 61 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Sep 19, 2025 | clinicaltrials |
| NCT04763915 | Improving Care After Inherited Cancer Testing(IMPACT) | active not recruiting | N/A | 720 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT05354440 | Post Marketing Clinical Follow Up of the BioProtect Balloon Implant System(CLP-10441) | active not recruiting | — | 80 | BioProtectINDUSTRY | 5 | Sep 19, 2025 | clinicaltrials |
| NCT05974774 | Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors | recruiting | Phase 3 | 1,600 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 19, 2025 | clinicaltrials |
| NCT07179783 | Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC) | recruiting | Phase 2 | 28 | Tianjin Medical University Second HospitalOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT04253483 | Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer | active not recruiting | Phase 2 | 14 | Rutgers, The State University of New JerseyOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT04858880 | Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy.(PROPER2) | recruiting | N/A | 374 | Lund University HospitalOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT02276430 | TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects(TACkLE) | active not recruiting | — | 939 | University Medical Center GroningenOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT03889119 | Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer | active not recruiting | N/A | 100 | Hoag Memorial Hospital PresbyterianOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT05871008 | Integrated Actionable Aging Assessment for Cancer Patients Pilot | active not recruiting | N/A | 35 | University of Colorado, DenverOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07172126 | Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets | not yet recruiting | Phase 1 / Phase 2 | 291 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07172685 | Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC | recruiting | N/A | 116 | Qilu Hospital of Shandong UniversityOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT01655836 | High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer | active not recruiting | Phase 1 | 42 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Sep 11, 2025 | clinicaltrials |
| NCT03678025 | Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer | recruiting | Phase 3 | 1,273 | SWOG Cancer Research NetworkNETWORK | 5 | Sep 11, 2025 | clinicaltrials |
| NCT06074510 | PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer(MIRROR) | active not recruiting | Phase 4 | 274 | Lantheus Medical ImagingINDUSTRY | 1 | Sep 11, 2025 | clinicaltrials |
| NCT01990521 | Prostate Screening Study Using MRI in BRCA Carriers | active not recruiting | N/A | 60 | Toronto Sunnybrook Regional Cancer CentreOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT05107674 | A Study of NX-1607 in Adults With Advanced Malignancies | recruiting | Phase 1 | 345 | Nurix Therapeutics, Inc.INDUSTRY | 2 | Sep 9, 2025 | clinicaltrials |
| NCT05600400 | Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer(iSMART) | recruiting | N/A | 144 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT05786742 | Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.(HYPO-5) | recruiting | N/A | 205 | CHU de Quebec-Universite LavalOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT06815354 | Comprehensive Assessment of Cancer Theranostic Response(TRAQinform) | recruiting | N/A | 32 | AIQ SolutionsINDUSTRY | 1 | Sep 9, 2025 | clinicaltrials |
| NCT07162987 | Prehabilitation to Patients With Prostate Cancer(PREPP) | recruiting | N/A | 20 | Odense University HospitalOTHER | 1 | Sep 9, 2025 | clinicaltrials |
| NCT04671693 | A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.(PASCA) | active not recruiting | N/A | 500 | Centre Leon BerardOTHER | 1 | Sep 5, 2025 | clinicaltrials |
| NCT03317990 | Evaluating the Effects of Frozen Section Technology on Oncological and Functional Outcomes at Radical Prostatectomy.(NeuroSAFEPROOF) | active not recruiting | N/A | 407 | University College, LondonOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT05336786 | Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount) | active not recruiting | Phase 3 | 70 | Thomas Jefferson UniversityOTHER | 2 | Sep 4, 2025 | clinicaltrials |
| NCT07155759 | Long-term Outcomes of Prostate Cancer Screening(STHLM3MRI_3) | active not recruiting | N/A | 7,500 | Karolinska InstitutetOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT06687421 | Implementation of Precision Medicine in High-risk Prostate Cancer(SPRINTR-REAL) | recruiting | — | 5,500 | Andreas JosefssonOTHER_GOV | 1 | Sep 3, 2025 | clinicaltrials |
| NCT06689163 | A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone | recruiting | Phase 1 / Phase 2 | 66 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Sep 3, 2025 | clinicaltrials |
| NCT06703437 | Long Acting Neuraxial Peri-prostatic Block in Cancer | active not recruiting | Phase 1 | 12 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Sep 3, 2025 | clinicaltrials |
| NCT07149831 | A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults | recruiting | Phase 1 | 6 | Sinotau Pharmaceutical GroupINDUSTRY | 1 | Sep 2, 2025 | clinicaltrials |
| NCT06331013 | CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr(PRO-SPEED) | recruiting | N/A | 60 | European Institute of OncologyOTHER | 1 | Aug 28, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Oct 7, 2025source: clinicaltrials